UnicoCell Biomed Co., Ltd. (TPE:6794)

UnicoCell Biomed Revenue

UnicoCell Biomed had revenue of 4.60M TWD in the quarter ending June 30, 2026, a decrease of -47.00%. This brings the company's total for the last twelve months to 22.46M, down -48.98% year-over-year. In the year 2025, UnicoCell Biomed had annual revenue of 30.10M, down -5.58%. That makes UnicoCell Biomed the 44,129th largest company in the world by revenue and 2,173rd in Taiwan.

• Revenue (ttm): 22.46M
• Revenue Growth: -48.98%
• P/S Ratio: 194.36
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.37B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Taiwan 28.07M 93.2%
• Japan 2.04M 6.8%

Fiscal year ended Dec 31, 2025 See the full UnicoCell Biomed breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	30.10M	-1.78M	-5.58%
Dec 31, 2024	31.88M	7.29M	29.66%
Dec 31, 2023	24.59M	10.19M	70.79%
Dec 31, 2022	14.40M	6.22M	76.07%
Dec 31, 2021	8.18M	4.20M	105.35%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 16, 2026

Data Sources Report a data error